Literature DB >> 20835267

A novel model of cholesterol efflux from lipid-loaded cells.

Di-xian Luo1, De-liang Cao, Yan Xiong, Xu-hong Peng, Duan-fang Liao.   

Abstract

Cholesterol efflux from lipid-loaded cells is a key athero-protective event that counteracts cholesterol uptake. The imbalance between cholesterol efflux and uptake determines the prevention or development of atherosclerosis. Many proteins and factors participate in the cholesterol efflux event. However, there are currently no systematic models of reverse cholesterol transport (RCT) that include most RCT-related factors and events. On the basis of recent research findings from other and our laboratories, we propose a novel model of one center and four systems with coupling transportation and networking regulation. This model represents a common way of cholesterol efflux; however, the systems in the model consist of different proteins/factors in different cells. In this review, we evaluate the novel model in vascular smooth muscle cells (VSMCs) and macrophages, which are the most important original cells of foam cells. This novel model consists of 1) a caveolae transport center, 2) an intracellular trafficking system of the caveolin-1 complex, 3) a transmembrane transport system of the ABC-A1 complex, 4) a transmembrane transport system of the SR-B1 complex, and 5) an extracelluar trafficking system of HDL/Apo-A1. In brief, the caveolin-1 system transports cholesterol from intracellular compartments to caveolae. Subsequently, both ABC-A1 and SR-B1 complex systems transfer cholesterol from caveolae to extracellular HDL/Apo-A1. The four systems are linked by a regulatory network. This model provides a simple and concise way to understand the dynamic process of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835267      PMCID: PMC4012915          DOI: 10.1038/aps.2010.93

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  143 in total

1.  A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo.

Authors:  A Schlegel; M P Lisanti
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

Review 2.  ABCA1. The gatekeeper for eliminating excess tissue cholesterol.

Authors:  J F Oram; R M Lawn
Journal:  J Lipid Res       Date:  2001-08       Impact factor: 5.922

3.  Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae.

Authors:  A Uittenbogaard; E J Smart
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

4.  A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.

Authors:  W R Oliver; J L Shenk; M R Snaith; C S Russell; K D Plunket; N L Bodkin; M C Lewis; D A Winegar; M L Sznaidman; M H Lambert; H E Xu; D D Sternbach; S A Kliewer; B C Hansen; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

5.  Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae).

Authors:  D Sviridov; N Fidge; G Beaumier-Gallon; C Fielding
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

Review 6.  Lipid droplets: proteins floating on a pool of fat.

Authors:  D A Brown
Journal:  Curr Biol       Date:  2001-06-05       Impact factor: 10.834

7.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1.

Authors:  P E Fielding; K Nagao; H Hakamata; G Chimini; C J Fielding
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

9.  Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.

Authors:  A Venkateswaran; B A Laffitte; S B Joseph; P A Mak; D C Wilpitz; P A Edwards; P Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

10.  A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance.

Authors:  A Pol; R Luetterforst; M Lindsay; S Heino; E Ikonen; R G Parton
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

View more
  15 in total

1.  Frontiers of vascular biology and disease research.

Authors:  Alex F Chen; Chao-shu Tang
Journal:  Acta Pharmacol Sin       Date:  2010-10       Impact factor: 6.150

Review 2.  Lipid metabolism and carcinogenesis, cancer development.

Authors:  Jia Long; Chan-Juan Zhang; Neng Zhu; Ke Du; Yu-Fang Yin; Xi Tan; Duan-Fang Liao; Li Qin
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

3.  Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.

Authors:  Neta Rimmerman; Heather B Bradshaw; Ewa Kozela; Rivka Levy; Ana Juknat; Zvi Vogel
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  Tissue cholesterol content alterations in streptozotocin-induced diabetic rats.

Authors:  Xin-ting Wang; Jia Li; Li Liu; Nan Hu; Shi Jin; Can Liu; Dan Mei; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2012-06-18       Impact factor: 6.150

5.  Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation: understanding the lipid paradox associated with rheumatoid arthritis.

Authors:  S Pérez-Baos; J I Barrasa; P Gratal; A Larrañaga-Vera; I Prieto-Potin; G Herrero-Beaumont; R Largo
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

6.  Ezetimibe suppresses cholesterol accumulation in lipid-loaded vascular smooth muscle cells in vitro via MAPK signaling.

Authors:  Li Qin; Yun-bo Yang; Yi-xin Yang; Neng Zhu; Yong-zhen Gong; Cai-ping Zhang; Shun-xiang Li; Duan-fang Liao
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

Review 7.  Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis.

Authors:  Li Qin; Neng Zhu; Bao-Xue Ao; Chan Liu; Ya-Ning Shi; Ke Du; Jian-Xiong Chen; Xi-Long Zheng; Duan-Fang Liao
Journal:  Int J Mol Sci       Date:  2016-03-22       Impact factor: 5.923

Review 8.  The Role of Caveolin 1 in HIV Infection and Pathogenesis.

Authors:  Ayalew Mergia
Journal:  Viruses       Date:  2017-05-26       Impact factor: 5.048

9.  Erchen Decoction Ameliorates Lipid Metabolism by the Regulation of the Protein CAV-1 and the Receptors VLDLR, LDLR, ABCA1, and SRB1 in a High-Fat Diet Rat Model.

Authors:  Shanshan Ding; Jie Kang; Ling Tong; Yuchen Lin; Linghong Liao; Bizhen Gao
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-08       Impact factor: 2.629

10.  Crosstalk Between LXR and Caveolin-1 Signaling Supports Cholesterol Efflux and Anti-Inflammatory Pathways in Macrophages.

Authors:  Cristina M Ramírez; Marta Torrecilla-Parra; Virginia Pardo-Marqués; Mario Fernández de-Frutos; Ana Pérez-García; Carlos Tabraue; Juan Vladimir de la Rosa; Patricia Martín-Rodriguez; Mercedes Díaz-Sarmiento; Uxue Nuñez; Marta C Orizaola; Paqui G Través; Marta Camps; Lisardo Boscá; Antonio Castrillo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-27       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.